- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for Parkinson’s Disease: How Good Are They?
Authors
Keywords
-
Journal
Neuroscience Bulletin
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-24
DOI
10.1007/s12264-019-00433-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased DJ-1 and α-Synuclein in Plasma Neural-Derived Exosomes as Potential Markers for Parkinson’s Disease
- (2019) Zhen-Hua Zhao et al. Frontiers in Aging Neuroscience
- Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease
- (2019) Lirong Jin et al. Frontiers in Neurology
- Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker
- (2019) Zhaofei Yang et al. Frontiers in Neuroscience
- The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
- (2019) Sara Lorio et al. Frontiers in Aging Neuroscience
- Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach
- (2019) Laura E. Jonkman et al. Neuroscience Bulletin
- Prodromal Parkinson's Disease: The Decade Past, the Decade to Come
- (2019) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
- (2019) Un Jung Kang et al. MOVEMENT DISORDERS
- Overview of Cost-effectiveness Analysis
- (2019) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Altered expression levels of microRNA-132 and Nurr1 in peripheral blood of Parkinson’s disease: a potential disease biomarker
- (2019) Zhaofei Yang et al. ACS Chemical Neuroscience
- Meta‐analyses identify differentially expressed micrornas in Parkinson's disease
- (2019) Jessica Schulz et al. ANNALS OF NEUROLOGY
- Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study
- (2019) Dilini Rathnayake et al. BMC Neurology
- Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson’s Disease
- (2019) Xiaoli Si et al. NEUROSCIENCE
- Combinatory microRNA serum signatures as classifiers of Parkinson's disease
- (2019) Ketan S. Patil et al. PARKINSONISM & RELATED DISORDERS
- New windows into the brain: Central nervous system-derived extracellular vesicles in blood
- (2019) Min Shi et al. PROGRESS IN NEUROBIOLOGY
- The early diagnosis of Parkinson's disease through combined biomarkers
- (2019) Xin‐Qiao Chen et al. ACTA NEUROLOGICA SCANDINAVICA
- The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology
- (2019) M. G. Førland et al. EUROPEAN JOURNAL OF NEUROLOGY
- Parkinson’s disease biomarkers based on α‐synuclein
- (2019) Muneera Fayyad et al. JOURNAL OF NEUROCHEMISTRY
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease
- (2019) Shijie Wang et al. EBioMedicine
- The utility of the combined use of 123I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes
- (2018) Eiji Matsusue et al. ACTA RADIOLOGICA
- Extracellular vesicles in neurodegenerative diseases
- (2018) Tommaso Croese et al. MOLECULAR ASPECTS OF MEDICINE
- The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
- (2018) Silvia Cerri et al. Frontiers in Cellular Neuroscience
- Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review
- (2018) Arun T Nair et al. Journal of Neurogastroenterology and Motility
- Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of “Protein-Misfolding Cyclic Amplification” and “Real-Time Quaking-Induced Conversion” as Diagnostic Tools
- (2018) Silvia Paciotti et al. Frontiers in Neurology
- Finding useful biomarkers for Parkinson’s disease
- (2018) Alice S. Chen-Plotkin et al. Science Translational Medicine
- Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson’s disease versus atypical Parkinsonian disorders
- (2018) S.F. Calloni et al. EUROPEAN JOURNAL OF RADIOLOGY
- Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
- (2018) Paula Perez-Pardo et al. GUT
- Microvessels may Confound the “Swallow Tail Sign” in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study
- (2018) Thomas Kau et al. JOURNAL OF NEUROIMAGING
- Serum soluble lymphocyte activation gene-3 as a diagnostic biomarker in Parkinson's disease: A pilot multicenter study
- (2018) Shi-shuang Cui et al. MOVEMENT DISORDERS
- CSF β-amyloid42 and risk of freezing of gait in early Parkinson disease
- (2018) Ryul Kim et al. NEUROLOGY
- Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
- (2018) Tianbai Li et al. Frontiers in Aging Neuroscience
- microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
- (2017) Loredana Leggio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Magnetic resonance imaging for the diagnosis of Parkinson’s disease
- (2017) Beatrice Heim et al. JOURNAL OF NEURAL TRANSMISSION
- Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
- (2017) Lori N. Eidson et al. Journal of Neuroinflammation
- Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
- (2017) Chin-Hsien Lin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Experimental Design in Clinical ‘Omics Biomarker Discovery
- (2017) Jenny Forshed JOURNAL OF PROTEOME RESEARCH
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
- (2017) Manuel Delgado-Alvarado et al. MOVEMENT DISORDERS
- Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients
- (2017) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
- (2017) Seyed-Mohammad Fereshtehnejad et al. MOVEMENT DISORDERS
- Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
- (2017) Paolo Eusebi et al. MOVEMENT DISORDERS
- Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
- (2017) Brit Mollenhauer et al. NEUROLOGY
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Region-Specific Iron Measured by MRI as a Biomarker for Parkinson’s Disease
- (2017) Xiaojun Guan et al. Neuroscience Bulletin
- Biomarker Discovery in Parkinson’s Disease: Present Challenges and Future Opportunities
- (2017) Song Li et al. Neuroscience Bulletin
- Biomarkers for Parkinson’s Disease: Recent Advancement
- (2017) Sharvari Lotankar et al. Neuroscience Bulletin
- Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson’s Disease
- (2017) Ying Wang et al. Neuroscience Bulletin
- Milestones of Parkinson’s Disease Research: 200 Years of History and Beyond
- (2017) Song Li et al. Neuroscience Bulletin
- Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease?
- (2017) Weidong Le et al. Neuroscience Bulletin
- Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease
- (2017) Michelle E. Fullard et al. Neuroscience Bulletin
- Premotor Diagnosis of Parkinson’s Disease
- (2017) Heinz Reichmann Neuroscience Bulletin
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
- (2017) Davide Chiasserini et al. Alzheimers Research & Therapy
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort
- (2017) Danna Jennings et al. JAMA Neurology
- Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease
- (2016) Laura Vella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
- (2016) Tainá M. Marques et al. MOLECULAR NEUROBIOLOGY
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
- (2016) Kyle B. Fraser et al. MOVEMENT DISORDERS
- Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
- (2016) Nour K. Majbour et al. MOVEMENT DISORDERS
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
- (2016) Un Jung Kang et al. MOVEMENT DISORDERS
- Monitoring of 30 marker candidates in early Parkinson disease as progression markers
- (2016) Brit Mollenhauer et al. NEUROLOGY
- Accuracy of clinical diagnosis of Parkinson disease
- (2016) Giovanni Rizzo et al. NEUROLOGY
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression
- (2015) Y. K. Wing et al. NEUROLOGY
- Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
- (2015) Fang Ba et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluidα-Synuclein Levels in Parkinson’s Disease: A Meta-Analysis
- (2015) Bo Zhou et al. Parkinsons Disease
- The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
- (2015) Sven R Suwijn et al. EJNMMI Research
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Gut microbiota are related to Parkinson's disease and clinical phenotype
- (2014) Filip Scheperjans et al. MOVEMENT DISORDERS
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and123I-Metaiodobenzylguanidine Scintigraphy
- (2013) F. Miyoshi et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
- (2013) Nin Bajaj et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
- (2013) Alex Iranzo et al. LANCET NEUROLOGY
- Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
- (2013) Megan K. Herbert et al. PARKINSONISM & RELATED DISORDERS
- Parkinson's Disease and Parkinsonism: Neuropathology
- (2013) D. W. Dickson Cold Spring Harbor Perspectives in Medicine
- Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson’s disease
- (2012) Werner Poewe et al. Expert Review of Neurotherapeutics
- Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
- (2012) Brit Mollenhauer et al. NEUROSCIENCE LETTERS
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Translating biomarkers to clinical practice
- (2011) R H Perlis MOLECULAR PSYCHIATRY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- What are biomarkers?
- (2010) Kyle Strimbu et al. Current Opinion in HIV and AIDS
- Prevalence of smell loss in Parkinson's disease – A multicenter study
- (2009) A. Haehner et al. PARKINSONISM & RELATED DISORDERS
- Peripheral cytokines profile in Parkinson’s disease
- (2008) M. Reale et al. BRAIN BEHAVIOR AND IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started